430 related articles for article (PubMed ID: 20819899)
21. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
[TBL] [Abstract][Full Text] [Related]
22. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis.
Shinwell ES; Eventov-Friedman S
Semin Fetal Neonatal Med; 2009 Jun; 14(3):164-70. PubMed ID: 19109083
[TBL] [Abstract][Full Text] [Related]
23. Postnatal dexamethasone for lung disease of prematurity.
Watchko JF; Brozanski BS
N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218577
[No Abstract] [Full Text] [Related]
24. Early closure of the Watterberg trial.
Roberts RS
Pediatrics; 2004 Dec; 114(6):1670-1. PubMed ID: 15574631
[No Abstract] [Full Text] [Related]
25. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
Doyle LW
Neonatology; 2021; 118(2):244-251. PubMed ID: 33975319
[TBL] [Abstract][Full Text] [Related]
26. Postnatal steroids: the way forward.
Halliday HL
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F158-9. PubMed ID: 21289014
[No Abstract] [Full Text] [Related]
27. Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction.
Gordon PV
Pediatrics; 2005 May; 115(5):1446-7; author reply 1447. PubMed ID: 15867074
[No Abstract] [Full Text] [Related]
28. [Postnatal steroid treatment--time to reconsider?].
Saugstad OD
Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3404. PubMed ID: 10553333
[No Abstract] [Full Text] [Related]
29. Dexamethasone and bronchopulmonary dysplasia.
Frank L; Lecuona PC
Pediatrics; 1996 Sep; 98(3 Pt 1):514-5. PubMed ID: 8784386
[No Abstract] [Full Text] [Related]
30. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
Rademaker KJ; de Vries LS; Uiterwaal CS; Groenendaal F; Grobbee DE; van Bel F
Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
[TBL] [Abstract][Full Text] [Related]
31. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
Watterberg KL; Walsh MC; Li L; Chawla S; D'Angio CT; Goldberg RN; Hintz SR; Laughon MM; Yoder BA; Kennedy KA; McDavid GE; Backstrom-Lacy C; Das A; Crawford MM; Keszler M; Sokol GM; Poindexter BB; Ambalavanan N; Hibbs AM; Truog WE; Schmidt B; Wyckoff MH; Khan AM; Garg M; Chess PR; Reynolds AM; Moallem M; Bell EF; Meyer LR; Patel RM; Van Meurs KP; Cotten CM; McGowan EC; Hines AC; Merhar S; Peralta-Carcelen M; Wilson-Costello DE; Kilbride HW; DeMauro SB; Heyne RJ; Mosquera RA; Natarajan G; Purdy IB; Lowe JR; Maitre NL; Harmon HM; Hogden LA; Adams-Chapman I; Winter S; Malcolm WF; Higgins RD;
N Engl J Med; 2022 Mar; 386(12):1121-1131. PubMed ID: 35320643
[TBL] [Abstract][Full Text] [Related]
32. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
Onland W; De Jaegere AP; Offringa M; van Kaam AH
Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
[TBL] [Abstract][Full Text] [Related]
33. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
[TBL] [Abstract][Full Text] [Related]
34. Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared.
Cole CH
Semin Neonatol; 2001 Aug; 6(4):343-50. PubMed ID: 11972435
[TBL] [Abstract][Full Text] [Related]
35. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
Grier DG; Halliday HL
Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
[TBL] [Abstract][Full Text] [Related]
36. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note.
Frank L
Pediatrics; 1991 Aug; 88(2):413-6. PubMed ID: 1741827
[No Abstract] [Full Text] [Related]
37. Postnatal steroids and neurodevelopmental outcomes: a problem in the making.
Barrington KJ
Pediatrics; 2001 Jun; 107(6):1425-6. PubMed ID: 11389269
[No Abstract] [Full Text] [Related]
38. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
Bassler D; van den Anker J
Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of dexamethasone in premature neonates.
Lugo RA; Nahata MC; Menke JA; McClead RE
Eur J Clin Pharmacol; 1996; 49(6):477-83. PubMed ID: 8706773
[TBL] [Abstract][Full Text] [Related]
40. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity.
Spinillo A; Viazzo F; Colleoni R; Chiara A; Maria Cerbo R; Fazzi E
Am J Obstet Gynecol; 2004 Jul; 191(1):217-24. PubMed ID: 15295369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
